177 related articles for article (PubMed ID: 18635969)
1. Signaling by dopamine regulates D2 receptors trafficking at the membrane.
Tirotta E; Fontaine V; Picetti R; Lombardi M; Samad TA; Oulad-Abdelghani M; Edwards R; Borrelli E
Cell Cycle; 2008 Jul; 7(14):2241-8. PubMed ID: 18635969
[TBL] [Abstract][Full Text] [Related]
2. Role of a Galphai2 protein splice variant in the formation of an intracellular dopamine D2 receptor pool.
López-Aranda MF; Acevedo MJ; Gutierrez A; Koulen P; Khan ZU
J Cell Sci; 2007 Jul; 120(Pt 13):2171-8. PubMed ID: 17550964
[TBL] [Abstract][Full Text] [Related]
3. Coupling of D2R Short but not D2R Long receptor isoform to the Rho/ROCK signaling pathway renders striatal neurons vulnerable to mutant huntingtin.
Galan-Rodriguez B; Martin E; Brouillet E; Déglon N; Betuing S; Caboche J
Eur J Neurosci; 2017 Jan; 45(1):198-206. PubMed ID: 27717053
[TBL] [Abstract][Full Text] [Related]
4. RGS2 modulates the activity and internalization of dopamine D2 receptors in neuroblastoma N2A cells.
Luessen DJ; Hinshaw TP; Sun H; Howlett AC; Marrs G; McCool BA; Chen R
Neuropharmacology; 2016 Nov; 110(Pt A):297-307. PubMed ID: 27528587
[TBL] [Abstract][Full Text] [Related]
5. Dopamine D2 receptor stimulation potentiates PolyQ-Huntingtin-induced mouse striatal neuron dysfunctions via Rho/ROCK-II activation.
Deyts C; Galan-Rodriguez B; Martin E; Bouveyron N; Roze E; Charvin D; Caboche J; Bétuing S
PLoS One; 2009 Dec; 4(12):e8287. PubMed ID: 20016831
[TBL] [Abstract][Full Text] [Related]
6. Schizophrenia, amphetamine-induced sensitized state and acute amphetamine exposure all show a common alteration: increased dopamine D2 receptor dimerization.
Wang M; Pei L; Fletcher PJ; Kapur S; Seeman P; Liu F
Mol Brain; 2010 Sep; 3():25. PubMed ID: 20813060
[TBL] [Abstract][Full Text] [Related]
7. Dopamine D2 Receptors Modulate Pyramidal Neurons in Mouse Medial Prefrontal Cortex through a Stimulatory G-Protein Pathway.
Robinson SE; Sohal VS
J Neurosci; 2017 Oct; 37(42):10063-10073. PubMed ID: 28912160
[TBL] [Abstract][Full Text] [Related]
8. Anaplastic Lymphoma Kinase Regulates Internalization of the Dopamine D2 Receptor.
He D; Lasek AW
Mol Pharmacol; 2020 Feb; 97(2):123-131. PubMed ID: 31734646
[TBL] [Abstract][Full Text] [Related]
9. Differential subcellular localization of two dopamine D2 receptor isoforms in transfected NG108-15 cells.
Takeuchi Y; Fukunaga K
J Neurochem; 2003 May; 85(4):1064-74. PubMed ID: 12716438
[TBL] [Abstract][Full Text] [Related]
10. RalA employs GRK2 and β-arrestins for the filamin A-mediated regulation of trafficking and signaling of dopamine D2 and D3 receptor.
Zheng M; Zhang X; Sun N; Min C; Zhang X; Kim KM
Biochim Biophys Acta; 2016 Aug; 1863(8):2072-83. PubMed ID: 27188791
[TBL] [Abstract][Full Text] [Related]
11. Cocaine modulates allosteric D
Beggiato S; Borelli AC; Borroto-Escuela D; Corbucci I; Tomasini MC; Marti M; Antonelli T; Tanganelli S; Fuxe K; Ferraro L
Cell Signal; 2017 Dec; 40():116-124. PubMed ID: 28923416
[TBL] [Abstract][Full Text] [Related]
12. Wnt5a-dopamine D2 receptor interactions regulate dopamine neuron development via extracellular signal-regulated kinase (ERK) activation.
Yoon S; Choi MH; Chang MS; Baik JH
J Biol Chem; 2011 May; 286(18):15641-51. PubMed ID: 21454669
[TBL] [Abstract][Full Text] [Related]
13. Capture of D2 dopamine receptor signaling complexes in striatal cells for mass spectrometry proteomic analysis.
Kabbani N; Nordman JC
Methods Mol Biol; 2013; 964():43-60. PubMed ID: 23296777
[TBL] [Abstract][Full Text] [Related]
14. Dopamine D2 receptor signaling dynamics of dopamine D2-neurotensin 1 receptor heteromers.
Borroto-Escuela DO; Ravani A; Tarakanov AO; Brito I; Narvaez M; Romero-Fernandez W; Corrales F; Agnati LF; Tanganelli S; Ferraro L; Fuxe K
Biochem Biophys Res Commun; 2013 May; 435(1):140-6. PubMed ID: 23624386
[TBL] [Abstract][Full Text] [Related]
15. The Role of the Dopamine D2 Receptor in Form-Deprivation Myopia in Mice: Studies With Full and Partial D2 Receptor Agonists and Knockouts.
Huang F; Wang Q; Yan T; Tang J; Hou X; Shu Z; Wan F; Yang Y; Qu J; Zhou X
Invest Ophthalmol Vis Sci; 2020 Jun; 61(6):47. PubMed ID: 32572456
[TBL] [Abstract][Full Text] [Related]
16. Regulation of type 1 IP₃ receptor expression by dopamine D2-like receptors via AP-1 and NFATc4 activation.
Mizuno K; Kurokawa K; Ohkuma S
Neuropharmacology; 2013 Aug; 71():264-72. PubMed ID: 23597509
[TBL] [Abstract][Full Text] [Related]
17. GIPC recruits GAIP (RGS19) to attenuate dopamine D2 receptor signaling.
Jeanneteau F; Guillin O; Diaz J; Griffon N; Sokoloff P
Mol Biol Cell; 2004 Nov; 15(11):4926-37. PubMed ID: 15356268
[TBL] [Abstract][Full Text] [Related]
18. Adenosine A2A-dopamine D2 receptor-receptor heteromerization: qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer.
Canals M; Marcellino D; Fanelli F; Ciruela F; de Benedetti P; Goldberg SR; Neve K; Fuxe K; Agnati LF; Woods AS; Ferré S; Lluis C; Bouvier M; Franco R
J Biol Chem; 2003 Nov; 278(47):46741-9. PubMed ID: 12933819
[TBL] [Abstract][Full Text] [Related]
19. Advanced research on dopamine signaling to develop drugs for the treatment of mental disorders: proteins interacting with the third cytoplasmic loop of dopamine D2 and D3 receptors.
Shioda N; Takeuchi Y; Fukunaga K
J Pharmacol Sci; 2010; 114(1):25-31. PubMed ID: 20716856
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the desensitization properties of five dopamine receptor subtypes and alternatively spliced variants of dopamine D2 and D4 receptors.
Cho DI; Beom S; Van Tol HH; Caron MG; Kim KM
Biochem Biophys Res Commun; 2006 Nov; 350(3):634-40. PubMed ID: 17022946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
